Response to ESAs Predicts ESRD Risk - Renal and Urology News PDF Print
Renal and Urology News
PHILADELPHIA—Patients with chronic kidney disease (CKD) who have a low response to erythropoiesis-stimulating agents (ESAs) are at increased risk of progressing to end-stage renal disease (ESRD), investigators reported at Kidney Week 2011.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.